AstraZeneca’s Internal Documents on Seroquel

May 20, 2009

These documents relate to this story on BNET:

beamish25

Jackson18

Goldstein%2044%20%5BRedacted%5D%20-%20Hagger%20email%20(08-07-03)

Goldstein%2031%20%5BRedacted%5D%20-%20BEST%20Mtg%20Minutes%20(11-24-04)

Goldstein11

Goldstein10

Goldstein09

Goldstein08

Dev%2012%20%5BRedacted%5D%20-%20Dev%20email%20(01-08-04)

Brennan%2026%20%5BRedacted%5D%20-%20Project%20Brief%20for%202005%20AACAP%20(02-14-05)

Brennan%2020%20%5BRedacted%5D%20-%20Hess%20email%20(05-26-04)

Brennan31

Brennan28

Brecher42

Brecher16

Brecher08

Brecher05

Birkett09

Beamish70

beamish27

beamish25

Advertisements

2 Responses to “AstraZeneca’s Internal Documents on Seroquel”

  1. Kent Sawdy Says:

    Do you have more documentationin regards to AstraZeneca’s intentions to promote Seroquel as an “off label” prescription?


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: